The Associations between Apolipoprotein E Gene Epsilon2/Epsilon3/Epsilon4 Polymorphisms and the Risk of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus.

Jian-Quan Luo,Huan Ren,Hoan Linh Banh,Mou-Ze Liu,Ping Xu,Ping-Fei Fang,Da-Xiong Xiang

DOI: https://doi.org/10.3389/fphys.2017.01031

IF: 4

2017-01-01

Frontiers in Physiology

Abstract:Background and Objective: Apolipoprotein E (APOE) plays important roles in lipoprotein metabolism and cardiovascular disease. Evidence suggests the APOE gene epsilon2/epsilon3/epsilon4 (epsilon 2/epsilon 3/epsilon 4) polymorphisms might be associated with the susceptibility of coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM). However, no clear consensus has yet been established. Therefore, the aim of thismeta-analysis is to provide a precise conclusion on the potential association between APOE epsilon 2/epsilon 3/epsilon 4 polymorphisms and the risk of CAD in patients with T2DM based on case-control studies. Methods: Pubmed, Embase, Chinese National Knowledge Infrastructure (CNKI), and Wanfang databases were searched for all relevant studies prior to August 2017 in English and Chinese language. The pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were used to assess the strength of the relationships. The between-study heterogeneity was evaluated by Cochran's Q-test and the I-2 index to adopt fixed- or random- effect models. Results: A total of 13 studies were eligible for inclusion. There was evidence for significant associations between APOE epsilon 4 mutation and the risk of CAD in patients with T2DM (for epsilon 3/epsilon 4 vs. epsilon 3/epsilon 3: OR = 1.69, 95% CI = 1.38-2.08, P < 0.001; for epsilon 4/epsilon 4 vs. epsilon 3/epsilon 3: OR = 2.72, 95% CI = 1.61-4.60, P < 0.001; for epsilon 4/epsilon 4 + epsilon 3/epsilon 4 vs. epsilon 3/epsilon 3: OR = 1.83, 95% CI = 1.52-2.22, P < 0.001; for + 4 allele vs. + 3 allele: OR = 1.64, 95% CI = 1.40-1.94, P < 0.001). In contrast, no significant associations were found in genetic model of APOE + 2 mutation (for epsilon 2/epsilon 2 vs. epsilon 3/epsilon 3: OR = 1.67, 95% CI = 0.90-3.09, P = 0.104; for epsilon 2/epsilon 3 vs. epsilon 3/epsilon 3: OR = 1.18, 95% CI = 0.93-1.51, P = 0.175; for epsilon 2/epsilon 2 + epsilon 2/epsilon 3 vs. epsilon 3/epsilon 3: OR = 1.26, 95% CI = 0.88-1.82, P = 0.212; for epsilon 2 allele vs. epsilon 3 allele: OR = 1.34, 95% CI = 0.98-1.84, P = 0.07). Conclusions: The APOE gene epsilon 4 mutation is associated with an increased risk of CAD in patients with T2DM, while the epsilon 2 variation has null association with this disease.